Castle Rock Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,185
| Closed | -$275K | – | 250 |
|
|
2025
Q1 | $275K | Buy |
2,185
+22
| +1% | +$2.77K | 0.07% | 196 |
|
|
2024
Q4 | $295K | Sell |
2,163
-426
| -16% | -$58.2K | 0.07% | 194 |
|
|
2024
Q3 | $369K | Buy |
2,589
+62
| +2% | +$8.85K | 0.09% | 178 |
|
|
2024
Q2 | $346K | Buy |
2,527
+238
| +10% | +$32.6K | 0.09% | 183 |
|
|
2024
Q1 | $296K | Buy |
2,289
+87
| +4% | +$11.3K | 0.08% | 192 |
|
|
2023
Q4 | $299K | Buy |
+2,202
| New | +$299K | 0.09% | 182 |
|
|
2023
Q2 | – | Sell |
-1,566
| Closed | -$205K | – | 218 |
|
|
2023
Q1 | $205K | Sell |
1,566
-329
| -17% | -$43K | 0.07% | 206 |
|
|
2022
Q4 | $260K | Buy |
+1,895
| New | +$260K | 0.12% | 184 |
|
|
2022
Q2 | – | Sell |
-1,898
| Closed | -$243K | – | 227 |
|
|
2022
Q1 | $243K | Sell |
1,898
-444
| -19% | -$56.8K | 0.11% | 201 |
|
|
2021
Q4 | $301K | Sell |
2,342
-241
| -9% | -$31K | 0.12% | 187 |
|
|
2021
Q3 | $407K | Buy |
2,583
+9
| +0.3% | +$1.42K | 0.14% | 170 |
|
|
2021
Q2 | $445K | Sell |
2,574
-54
| -2% | -$9.34K | 0.16% | 157 |
|
|
2021
Q1 | $406K | Buy |
2,628
+125
| +5% | +$19.3K | 0.16% | 175 |
|
|
2020
Q4 | $412K | Buy |
2,503
+501
| +25% | +$82.5K | 0.17% | 169 |
|
|
2020
Q3 | $269K | Buy |
2,002
+493
| +33% | +$66.2K | 0.18% | 137 |
|
|
2020
Q2 | $208K | Buy |
+1,509
| New | +$208K | 0.12% | 181 |
|
|
2020
Q1 | – | Sell |
-2,117
| Closed | -$260K | – | 149 |
|
|
2019
Q4 | $260K | Sell |
2,117
-13
| -0.6% | -$1.6K | 0.23% | 135 |
|
|
2019
Q3 | $234K | Sell |
2,130
-677
| -24% | -$74.4K | 0.24% | 128 |
|
|
2019
Q2 | $311K | Buy |
+2,807
| New | +$311K | 0.35% | 98 |
|
|
2018
Q4 | – | Sell |
-2,169
| Closed | -$235K | – | 49 |
|
|
2018
Q3 | $235K | Buy |
2,169
+286
| +15% | +$31K | 0.37% | 97 |
|
|
2018
Q2 | $207K | Buy |
+1,883
| New | +$207K | 0.28% | 112 |
|